Results 71 to 80 of about 1,416 (129)

Do immunosuppressive treatments influence immune responses against adenovirus-based COVID-19 vaccines in patients with multiple sclerosis? An Argentine multicenter study

Frontiers in Immunology
IntroductionThere are no reports in LATAM related to longitudinal humoral and cellular response to adenovirus based COVID-19 vaccines in people with Multiple Sclerosis (pwMS) under different disease modifying therapies (DMTs) and neutralization of the ...
Berenice Anabel Silva, Berenice Anabel Silva, Berenice Anabel Silva, Esteban Miglietta, Juan Cruz Casabona, Shirley Wenker, María Bárbara Eizaguirre, Ricardo Alonso, Magdalena Casas, Luciana Grimanesa Lázaro, Federico Man, Gustavo Portuondo, Abril Lopez Bisso, Noelia Zavala, Federico Casales, Gastón Imhoff, Dra Judith Steinberg, Pablo Adrián López, Edgar Carnero Contentti, Norma Deri, Vladimiro Sinay, Javier Hryb, Edson Chiganer, Felisa Leguizamon, Verónica Tkachuk, Johana Bauer, Flavia Ferrandina, Susana Giachello, Paula Henestroza, Orlando Garcea, Carla Antonela Pascuale, Mauro Heitrich, Osvaldo L. Podhajcer, Sabrina Vinzón, Tomas D’Alotto-Moreno, Alejandro Benatar, Gabriel Adrián Rabinovich, Fernando J. Pitossi, Carina C. Ferrari   +38 more
doaj   +1 more source

[Clinical and radiological effectiveness of natalizumab extended dosage interval in patients with relapsing multiple sclerosis]. [PDF]

Rev Neurol, 2022
García-Estévez DA, Pérez-Lorenzo G, Fernández-Pérez MJ, Cid-Rodríguez C, Ozaita-Arteche G.   +4 more
europepmc   +1 more source

[Periodic plasmapheresis as maintenance treatment in relapsing-remitting multiple sclerosis, a new therapeutic line? A case report]. [PDF]

Rev Neurol, 2022
Lafuente-Gómez G, Anaya-Fernández Lomana F, Gómez-Roldós A, García-Domínguez JM, Lozano-Ros A, Cuello JP, Higueras-Hernández Y, Meldaña-Rivera A, Goicochea-Briceño H, Leal-Hidalgo R, De Miguel-Sánchez de Puerta CJ, Martínez-Ginés ML.   +11 more
europepmc   +1 more source

Encefalitis anti-NMDA-R secundaria a infección por SARS-CoV-2

Neurología, 2020
G. Álvarez Bravo, L. Ramió i Torrentà
doaj   +1 more source

SARS-CoV-2 infection and seroprevalence in patients with multiple sclerosis. [PDF]

Neurologia (Engl Ed), 2021
Piñar Morales R, Ramírez Rivas MA, Barrero Hernández FJ.   +2 more
europepmc   +1 more source

Real-world experience of ocrelizumab in multiple sclerosis patients in Latin America. [PDF]

Arq Neuropsiquiatr, 2021
Rojas JI, Patrucco L, Fruns M, Hornung G, Flores J, Carnero Contentti E, Lopez PA, Pettinicchi JP, Caride A, Galleguillos L, Barahona J, Diaz V, Hernández M, Alonso R, Alonso R, Cristiano E.   +15 more
europepmc   +1 more source

Erratum to ‘‘Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm’’ [Neurologia. 2020;35(6):357–362]

Neurología (English Edition), 2020
G. Valero-López, E. Carreón-Guarnizo, R. Hernández-Clares, F. Iniesta-Martínez, J. Jiménez-Veiga, A. Moreno-Docon, M.A. Iborra-Bendicho, E. Aznar-Robles, M.F. Hellín-Gil, A. Morales-Ortiz, J.E. Meca-Lallana   +10 more
doaj   +1 more source

[Clinical and obstetric characteristics in women with multiple sclerosis during pregnancy]. [PDF]

Rev Med Inst Mex Seguro Soc
Nava-Escobar ER, Mireles-Ramírez MA, Torres-Mendoza BM, Hernández-Preciado MR, Sánchez-Rosales NA, Márquez-Pedroza J.   +5 more
europepmc   +1 more source

Age, motor dysfunction and neuropsychiatric symptoms impact quality of life in multiple sclerosis. [PDF]

Rev Bras Enferm, 2022
Brandão PMF, Lino TB, Oliveira RT, Parra AV, Andrade PHM, Christofoletti G.   +5 more
europepmc   +1 more source

Visceral leishmaniasis in a multiple sclerosis patient: a rare complication of fingolimod-induced lymphopenia. [PDF]

Rev Esp Quimioter
García-Alabarce A, Cornejo-Calvo E, de Salazar-González A, Guirao-Arrabal E.   +3 more
europepmc   +1 more source